Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus
Year: 2016
Type: article
Authors: Jiayi Xu, Songnian Lin, Robert W. Myers, George Addona, Joel P. Berger, Brian Campbell, Hsuan-shen Chen, Zhesheng Chen, George J. Eiermann, Nadine H. Elowe, Brian T. Farrer, Wen Feng, Qinghong Fu, Roman Kats-Kagan, Michael Kavana, Sunita Malkani, Daniel R. McMasters, Kaushik Mitra, Michele J. Pachanski, Xinchun Tong, Maria E. Trujillo, Libo Xu, Bei Zhang, Fengqi Zhang, Rui Zhang, Emma R. Parmee
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2548096922